Rob Schrepfer is currently the President of North American Generics at McKesson, where they lead strategic initiatives in the pharmaceutical industry. They previously held several roles, including Vice President of Business Development and Contract Manufacturing at ANI Pharmaceuticals, and Managing Director at Bear Stearns, focusing on pharmaceuticals and equity research. With a strong background in business development, finance, and healthcare investing, Rob has served on various boards and has experience in physical therapy, further enriching their diverse portfolio. They are pursuing an MBA in Health Sector Finance from Duke University, alongside a Master's in Physical Therapy from the University of Indianapolis and a Bachelor's in English from The University of Kansas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices